Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
Wakatsuki
Akihiko
A
Okatani
Yuji
Y
Fukaya
Takao
T
D000279:Administration, Cutaneous; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic / Q000009:adverse effects; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000494:pharmacology; D008875:Middle Aged; D017698:Postmenopause; D012306:Risk; D019821:Simvastatin / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D004966:Estrogens, Conjugated (USP); D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein; D019821:Simvastatin; D017258:Medroxyprogesterone Acetate